a few people working at a table

Press Releases

Ladenburg Thalmann Acts as Sole Book-Running Manager for Nuwellis, Inc. in its $11.04 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Transaction Information Nuwellis, Inc. (Nasdaq: NUWE) announced the closing of an underwritten public offering...

Ladenburg Thalmann Acts as Manager for Rhythm Pharmaceuticals, Inc. in its $124.8 Million Public Offering

Transaction Information Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM) announced the closing of its public offering...

Ladenburg Acts as Exclusive Placement Agent and Exclusive Warrant Solicitation Agent in $5.3 Million Offering for NovaBay Pharmaceuticals, Inc.

Transaction Information NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announced it has entered into a...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Palisade Bio, Inc. in its $13.8 Million Underwritten Public Offering

Transaction Information Palisade Bio, Inc. (Nasdaq: PALI) announced the closing of its previously announced...

Ladenburg Thalmann Acts as Exclusive Financial Advisor to Phosphorex's Majority Acquisition by Ampersand Capital Partners

Transaction Information Phosphorex Inc. announced a majority acquisition by Ampersand Capital Partners, a...

Ladenburg Thalmann Acts as Exclusive Warrant Inducement Agent in Ra Medical's (RMED) $6.2M Warrant Repricing and Announces Strategic Merger Plans with Catheter Precision Inc.

Transaction Information Ra Medical Systems, Inc. (NYSE American: RMED) ("Ra Medical" or the "Company") announced...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Kiora Pharmaceuticals, Inc. in its $6.0 Million Underwritten Public Offering

Transaction Information Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced the closing of an underwritten...

Ladenburg Thalmann Acts as Exclusive Financial Advisor to Athenex, Inc. (Nasdaq: ATNX) in its $85 Million Royalty Monetization

Transaction Information Athenex, Inc. (NASDAQ: ATNX, "Athenex", or "the Company) is a global biopharmaceutical...

Ladenburg Thalmann Acts as Exclusive Placement Agent for Vallon Pharmaceuticals, Inc. (VLON) in its $3.9 Million Registered Direct Offering

Transaction Information Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) announced that it has entered into...

  • 1
  • ...
  • 8
  • ...
  • 50